A Phase 3b, Randomized, Controlled Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer

Enrollment
This study is currently enrolling.
Associated Conditions
- Urology of Denver
Research Area
Colorado Cancer Research
Location

Porter, Colorado
Principal Investigator

Lawrence Karsh, MD, FACS, CPI
Sponsor

Ferring Pharmaceuticals

Enrollment Form

This study is currently enrolling.